Bertels, C., Dirven, I., Stevens, L., Geeraerts, X., Lescrauwaet, L., Geens, W., Del'haye, J., Brock, S., Vanbinst, A., Everaert, H., Vaeyens, F., Tuyaerts, S., Kockx, M., Duerinck, J., Neyns, B. (2025). Immunohistochemical and gene expression profiles as predictors of survival in recurrent high-grade glioma treated with intracranial nivolumab, ipilimumab, and autologous CD1c(BDCA-1) + /CD141(BDCA-3) + myeloid dendritic cells (myDC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.2071